Patient information were not provided.
The expiration date refers to the sterile finished product.
The complained inspire 7 start oxygenator (catalog number 050726, lot 2104290006) is not distributed in the usa, therefore the udi is not applicable.
The oxygenator item 050726 is similar to the inspire 7 oxygenator 050725, which is distributed in the usa, for which the device identifier is (b)(4).
The product item 050726 is not distributed in the usa, but it is similar to the inspire 7 oxygenator item 050725, which is distributed in the usa (510(k) number: k190690).
The device manufacture date refers to manufacture date of the sterile, finished oxygenator.
Sorin group (b)(4) manufactures the inspire 7 start hollow fiber oxygenator.
The incident occurred in (b)(6).
The involved device has been requested for return to sorin group (b)(4) for investigation and received on 23/08/2021.
The device has been sent to gamma ray decontamination on 31/08/2021, as per livanova procedure.
During follow up with the customer, following information were received: event occurred on (b)(6) 2021 and patient died on (b)(6) 2021 patient had critical clinical history.
On-going surgery was an aortic arch replacement (redo surgery).
Three different by-pass times have been identified, change-out of the oxygenator was likely done during first by-pass time.
No decay in overall gas exchange performances of the unit/s has been identified.
Act times were maintained below 450 seconds during by-pass.
Pump sheet has been received at livanova.
Device under investigation in correlation with pump sheet information.
In accordance with medical assessment performed by livanova clinical team, the reported low performance is well known issue reported in literature due to platelets adhesion.
Oxygenator replacement is requested in case of low performance and in the reported event the replacement has not been performed.
3 bypass occurred during surgery and time between each other is quite long and could increase the adhesion.
The reported clinical condition was very critical surgery with high risk of mortality.
If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.
|
Sorin group (b)(4) has received a report that, at the begin of an extra-corporeal circulation procedure, progressive increased transmembrane pressure was observed during use of an inspire 7 start p oxygenator.
According to customer, also a decrease of oxygenator performance was observed.
The patient died on (b)(6) 2021.
|